← k3vl4r
Log inGet started →

SVRA (Savara Inc) Price Forecast

AI-generated price forecast for Savara Inc (SVRA) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads SVRA as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 4.69. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

4.69

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

SVRA forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+13.65%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called SVRA's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest SVRA news

From the market-news feed the forecasts are read against.

  • Savara Announces New Employment Inducement Grant · Yahoo · Nov 12
  • HC Wainwright & Co. Assumes Savara at Buy, Announces Price Target of $10 · Benzinga · Nov 12
  • Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment · Yahoo · Oct 21
  • Savara Presents Clinical Trial Post-Hoc Analysis Of IMPALA At CHEST 2026 Annual Meeting To Evaluate Effects Of Molgramostim In aPAP Patients · Benzinga · Oct 21

🔒

See the full SVRA forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

SVRA forecast — frequently asked

Will SVRA go up?

K3vl4r's calibrated AI forecast currently reads SVRA as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the SVRA price prediction for 2026?

K3vl4r's model projects SVRA toward $5.46 over the next ~4 weeks, a +13.6% move from $4.80. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

CRDLBHCGRFSTAKDNTHIMMPERNAVCELVTGNALCMREOAHCOKTTAWGS

Will SVRA reach…?

Will SVRA reach $10.00?Will SVRA reach $20.00?Will SVRA reach $25.00?

Or see the full SVRA price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare SVRA

SVRA vs CRDLSVRA vs BHCSVRA vs GRFSSVRA vs TAKSVRA vs DNTHSVRA vs IMMP

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.